HARDING LOEVNER LP Regeneron Pharmaceuticals, Inc. Transaction History

HARDING LOEVNER LP portfolio value:

$8,000
portfolio value

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 11 shares 8K $688.87 11
Q3 2021 share Decrease -100.00% -11 shares -6K $605.18 0
Q2 2021 share 0.00% 0 shares 1K $558.54 11
Q1 2021 share Decrease -57.69% -15 shares -8K $473.14 11
Q4 2020 share Decrease -7.14% -2 shares -3K $483.11 26
Q3 2020 share Decrease -3.45% -1 shares -2K $559.78 28
Q2 2020 share Decrease -99.83% -16.71K shares -8.15M $623.65 29
Q1 2020 share Decrease -97.24% -590.59K shares -219.86M $488.29 16.74K
Q4 2019 share Decrease -12.27% -84.93K shares 36.00M $375.48 607.34K
Q3 2019 share Increase +0.41% 2.85K shares -23.75M $277.4 692.27K
Q2 2019 share Decrease -1.42% -9.90K shares -71.36M $313 689.42K
Q1 2019 share Increase +2.73% 18.59K shares 32.90M $410.62 699.32K
Q4 2018 share Increase +6.88% 43.83K shares -3.08M $373.5 680.73K
Q3 2018 share Increase +2.95% 18.25K shares 43.90M $404.04 636.89K
Q2 2018 share Decrease -1.11% -6.92K shares -2.22M $344.99 618.63K
Q1 2018 share Decrease -1.00% -6.34K shares -21.92M $344.36 625.56K
Q4 2017 share Decrease -2.45% -15.86K shares -52.06M $375.96 631.91K
Q3 2017 share Increase +21.86% 116.19K shares 28.55M $447.12 647.77K
Q2 2017 share Decrease -4.63% -25.81K shares 45.08M $491.14 531.58K
Q1 2017 share Increase +76.82% 242.16K shares 100.27M $387.51 557.4K
Q4 2016 share Decrease -1.04% -3.32K shares -12.34M $367.09 315.23K
Q3 2016 share Increase +91.74% 152.42K shares 70.04M $402.02 318.56K
Q2 2016 share Increase 0.00% 166.14K shares 58.02M $349.23 166.14K